COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCER TREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING

被引：0
|
作者：
Kawalec, P. [1 ]
Szawlowski, A. [2 ,3 ]
Federowicz, I [2 ,3 ]
Szkultecka-Debek, M. [4 ]
Russel-Szymczyk, M. [4 ]
机构：
[1] Centrum HTA, Krakow, Poland
[2] M Sklodowska Curie Mem Canc Ctr, Warsaw, Poland
[3] Inst Oncol, Warsaw, Poland
[4] Roche Polska, Warsaw, Poland
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66580-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A473 / A473
页数：1
相关论文
共 50 条
  • [11] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results.
    Kang, Y.
    Kang, W. K.
    Shin, D. B.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Salas, M. P.
    Suarez, T.
    Santamaria, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 183S - 183S
  • [12] Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine after radical gastrectomy for advanced gastric cancer
    Lee, H.
    Choi, Y.
    Hur, W.
    Kwon, H.
    Kim, M.
    Jung, G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S303 - S304
  • [13] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (PTS) with advanced gastric cancer (AGC):: Subgroup analyses confirm main efficacy findings
    Kang, Yoon Koo
    Kang, Won Ki
    Shin, Dong Bok
    Chen, Jia
    Xiong, Jianping
    Wang, Jie Jun
    Lichinitser, Mikhail
    Philco, Manuel
    Suarez, Tirso
    Santamaria, Julio
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 308 - 308
  • [14] Economic assessment of capecitabinexisplatin versus 5-FU/Cisplatin regimens in adjuvant treatment of advanced gastric cancer in Spain
    Darba, J.
    Restovic, G.
    De Arellano, Ramirez A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 50 - 50
  • [15] Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.
    Yu, Irene
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [16] Capecitabine/cisplatin vs. continuous infusion of 5-FU/cisplatin as first-line therapy in patients (pts) with advanced gastric cancer (AGC):: a randomised phase III trial
    Kang, Y.
    Kang, W.
    Shin, D.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Philco, M.
    Suarez, T.
    Santamaria, J.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 259 - 259
  • [17] CISPLATIN, DOXORUBICIN, AND 5-FU IN COMBINATION FOR ADVANCED GASTRIC-CANCER
    VOGL, SE
    ENGSTROM, PF
    [J]. CANCER TREATMENT REPORTS, 1984, 68 (10): : 1273 - 1275
  • [18] Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer:Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
    Hyung-SikLee
    YoungminChoi
    Won-JooHur
    Hyo-JinKim
    Hyuk-ChanKwon
    Sung-HyunKim
    Jae-SeokKim
    Jong-Hoon Lee
    Ghap-JoongJung
    Min-ChanKim
    [J]. World Journal of Gastroenterology, 2006, (04) : 603 - 607
  • [19] Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
    Lee, Hyung-Sik
    Choi, Youngmin
    Hur, Won-Joo
    Kim, Hyo-In
    Kwon, Hyuk-Chan
    Kim, Sung-Hyun
    Kim, Jae-Seok
    Lee, Jong-Hoon
    Jung, Ghap-Joong
    Kim, Min-Chan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (04) : 603 - 607
  • [20] Comparison of 5-FU versus capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer
    Yu, Irene S.
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345